array:24 [
  "pii" => "S0873215915302889"
  "issn" => "08732159"
  "doi" => "10.1016/S0873-2159(15)30288-9"
  "estado" => "S350"
  "fechaPublicacion" => "2008-11-01"
  "aid" => "6"
  "copyright" => "Sociedade Portuguesa de Pneumologia/SPP"
  "copyrightAnyo" => "2008"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Pneumol. 2008;14:803-27"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3013
    "formatos" => array:3 [
      "EPUB" => 237
      "HTML" => 2041
      "PDF" => 735
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0873215915302890"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30289-0"
    "estado" => "S350"
    "fechaPublicacion" => "2008-11-01"
    "aid" => "7"
    "copyright" => "Sociedade Portuguesa de Pneumologia/SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2008;14:829-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2425
      "formatos" => array:3 [
        "EPUB" => 243
        "HTML" => 1487
        "PDF" => 695
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "An&#225;lise comparativa entre tuberculose multirresistente e tuberculose extensivamente resistente &#8211; Epidemiologia e factores preditivos"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "829"
          "paginaFinal" => "842"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis &#8211; Epidemiology and predictive factors"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Sofia Vilari&#231;a, Carlos Gomes, Jaime Pina"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Sofia Vilari&#231;a"
            ]
            1 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Gomes"
            ]
            2 => array:2 [
              "nombre" => "Jaime"
              "apellidos" => "Pina"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302890?idApp=UINPBA00004E"
    "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302890/v1_201509151433/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0873215915302877"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30287-7"
    "estado" => "S350"
    "fechaPublicacion" => "2008-11-01"
    "aid" => "5"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2008;14:787-802"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2509
      "formatos" => array:3 [
        "EPUB" => 220
        "HTML" => 1540
        "PDF" => 749
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "Corpos estranhos na via a&#233;rea&#58; Experi&#234;ncia de um quarto de s&#233;culo"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "787"
          "paginaFinal" => "802"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Foreign bodies in the airway&#58; A quarter of a century&#8217;s experience"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Roda, Susana Nobre, Jorge Pires, M&#46; Helena Est&#234;v&#227;o, Miguel F&#233;lix"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Juliana"
              "apellidos" => "Roda"
            ]
            1 => array:2 [
              "nombre" => "Susana"
              "apellidos" => "Nobre"
            ]
            2 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Pires"
            ]
            3 => array:2 [
              "nombre" => "M&#46; Helena"
              "apellidos" => "Est&#234;v&#227;o"
            ]
            4 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "F&#233;lix"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302877?idApp=UINPBA00004E"
    "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302877/v1_201509151433/pt/main.assets"
  ]
  "pt" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
    "titulo" => "Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "803"
        "paginaFinal" => "827"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; Ara&#250;jo, B&#46; Parente, R&#46; Sotto-Mayor, E&#46; Teixeira, T&#46; Almod&#244;var, F&#46; Barata, H&#46; Queiroga, C&#46; Pereira, H&#46; Pereira, F&#46; Negreiro, C&#46; Silva"
        "autores" => array:11 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Ara&#250;jo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "af0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "B&#46;"
            "apellidos" => "Parente"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">2</span>"
                "identificador" => "af0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "R&#46;"
            "apellidos" => "Sotto-Mayor"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">3</span>"
                "identificador" => "af0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "E&#46;"
            "apellidos" => "Teixeira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">4</span>"
                "identificador" => "af0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "T&#46;"
            "apellidos" => "Almod&#244;var"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">5</span>"
                "identificador" => "af0025"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "F&#46;"
            "apellidos" => "Barata"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">6</span>"
                "identificador" => "af0030"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "H&#46;"
            "apellidos" => "Queiroga"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">7</span>"
                "identificador" => "af0035"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Pereira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">8</span>"
                "identificador" => "af0040"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "H&#46;"
            "apellidos" => "Pereira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">9</span>"
                "identificador" => "af0045"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "F&#46;"
            "apellidos" => "Negreiro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">10</span>"
                "identificador" => "af0050"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Silva"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">11</span>"
                "identificador" => "af0055"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:11 [
          0 => array:3 [
            "entidad" => "Coordenador da Cl&#237;nica de Patologia do Pulm&#227;o&#44; Servi&#231;o de Oncologia M&#233;dica&#44; Instituto Portugu&#234;s de Oncologia Francisco Gentil &#8211; Centro do Porto&#44; Portugal &#47; Francisco Gentil Portuguese Oncology Institute&#44; Centro do Porto&#44; Lung Pathology Clinic Coordinator&#44; Medical Oncology Unit&#44; Porto&#44; Portugal"
            "etiqueta" => "1"
            "identificador" => "af0005"
          ]
          1 => array:3 [
            "entidad" => "Directora do Servi&#231;o de Pneumologia&#44; Servi&#231;o de Pneumologia&#44; Centro Hospitalar de V&#46; N&#46; Gaia&#44; Portugal &#47; Centro Hospitalar de V&#46; N&#46; Gaia&#44; Head&#44; Pulmonology Unit&#44; Pulmonology Unit&#44; V&#46; N&#46; Gaia&#44; Portugal"
            "etiqueta" => "2"
            "identificador" => "af0010"
          ]
          2 => array:3 [
            "entidad" => "Chefe de Servi&#231;o de Pneumologia&#44; Servi&#231;o de Pneumologia do Hospital de Santa Maria&#44; CHLN&#44; Lisboa&#44; Portugal &#47; Head&#44; Pulmonology Unit&#44; Pulmonology Unit&#44; Hospital de Santa Maria&#44; CHLN&#44; Lisbon&#44; Portugal"
            "etiqueta" => "3"
            "identificador" => "af0015"
          ]
          3 => array:3 [
            "entidad" => "Assistente Graduada de Pneumologia&#44; Servi&#231;o de Pneumologia&#44; Hospital de Santa Maria&#44; Lisboa&#44; Portugal &#47; Hospital de Santa Maria&#44; Consultant&#44; Pulmonology specialist&#44; Pulmonology Unit&#44; Lisbon&#44; Portugal"
            "etiqueta" => "4"
            "identificador" => "af0020"
          ]
          4 => array:3 [
            "entidad" => "Servi&#231;o de Pneumologia&#59; Instituto Portugu&#234;s de Oncologia de Francisco Gentil&#44; Lisboa&#44; Portugal &#47; Pulmonology Unit&#44; Francisco Gentil Portuguese Oncology Institute&#44; Lisbon&#44; Portugal"
            "etiqueta" => "5"
            "identificador" => "af0025"
          ]
          5 => array:3 [
            "entidad" => "Respons&#225;vel de Pneumologia Oncol&#243;gica&#44; Centro Hospitalar de Coimbra&#44; Portugal &#47; Head&#44; Pulmonary Oncology&#44; Centro Hospitalar de Coimbra&#44; Portugal"
            "etiqueta" => "6"
            "identificador" => "af0030"
          ]
          6 => array:3 [
            "entidad" => "Coordenador da Consulta de Pneumologia Oncol&#243;gica&#44; Hospital de S&#46; Jo&#227;o&#44; Porto&#59; Portugal &#47; Pulmonary Oncology Appointment Coordinator&#44; Hospital de S&#46; Jo&#227;o&#44; Porto&#44; Portugal"
            "etiqueta" => "7"
            "identificador" => "af0035"
          ]
          7 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Pharmacoeconomic Manager</span>&#44; Departamento de Market Access &#38; Health Economics&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#59; Portugal &#47; Pharmacoeconomic Manager&#44; Market Access &#38; Health Economics Unit&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal"
            "etiqueta" => "8"
            "identificador" => "af0040"
          ]
          8 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Medical Manager</span> Oncologia Pulm&#227;o&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal &#47; Medical Manager&#44; Pulmonary Oncology&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal"
            "etiqueta" => "9"
            "identificador" => "af0045"
          ]
          9 => array:3 [
            "entidad" => "Bioestatista&#44; <span class="elsevierStyleItalic">Eurotrials</span> - Consultores Cient&#237;ficos&#44; Lisboa&#44; Portugal &#47; Biostatistician&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisbon&#44; Portugal"
            "etiqueta" => "10"
            "identificador" => "af0050"
          ]
          10 => array:3 [
            "entidad" => "Bioestatista S&#233;nior&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisboa&#59; Portugal &#47; Senior Biostatistician&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisbon&#44; Portugal"
            "etiqueta" => "11"
            "identificador" => "af0055"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2008-08-22"
    "fechaAceptado" => "2008-09-11"
    "PalabrasClave" => array:2 [
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras-chave"
          "identificador" => "xpalclavsec570064"
          "palabras" => array:5 [
            0 => "Cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
            1 => "econ&#243;mico"
            2 => "Portugal"
            3 => "utilidade"
            4 => "custo-efectividade"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key-words"
          "identificador" => "xpalclavsec570065"
          "palabras" => array:5 [
            0 => "Non-small cell lung cancer"
            1 => "economics"
            2 => "Portugal"
            3 => "utility"
            4 => "cost-effectiveness"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="as0005" class="elsevierStyleSection elsevierViewall"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Objectivo&#58;</span> Avaliar o custo-efectividade de erlotinib na segunda ou terceira linha do tratamento do cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas &#40;CPNPC&#41; avan&#231;ado ou metastizado <span class="elsevierStyleItalic">versus</span> docetaxel&#44; pemetrexedo ou tratamento de suporte&#46;</p><p id="sp0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Material e m&#233;todos&#58;</span> An&#225;lises de minimiza&#231;&#227;o de custos e custo-utilidade&#46; Horizonte temporal&#58; dois anos&#46; Perspectiva do Sistema Nacional de Sa&#250;de &#40;SNS&#41; portugu&#234;s&#46; Sobreviv&#234;ncia e tempo at&#233; progress&#227;o obtidos a partir de tr&#234;s ensaios cl&#237;nicos&#46; An&#225;lise-base inclui doentes com CPNPC avan&#231;ado ou metastizado em segunda ou terceira linhas&#46; Anos de vida ajustados pela qualidade &#40;ou QALY&#41; obtidos a partir de estudo no Reino Unido&#46; Consumo de recursos estimado por painel de peritos portugueses&#46; Inclu&#237;ram-se apenas custos directos&#44; obtidos a partir de fontes oficiais &#40;pre&#231;os actualizados para 2008&#41;&#46; Taxa de actualiza&#231;&#227;o anual&#58; 5&#37;&#46; An&#225;lises de sensibilidade&#58; diferentes subpopula&#231;&#245;es&#44; horizonte temporal a tr&#234;s anos e an&#225;lise probabil&#237;stica&#46;</p><p id="sp0015" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Resultados&#58;</span> O custo total&#47;doente foi menor com erlotinib &#40;26 478&#8364;&#41; <span class="elsevierStyleItalic">versus</span> docetaxel &#40;29 262&#8364;&#41; ou pemetrexedo &#40;32 762&#8364;&#41; e superior <span class="elsevierStyleItalic">versus</span> tratamento de suporte &#40;16 112&#8364;&#41;&#46; Obtiveram-se QALY&#47;doente mais elevados com erlotinib &#40;0&#44;250&#41; <span class="elsevierStyleItalic">versus</span> docetaxel &#40;0&#44;225&#41;&#44; pemetrexedo &#40;0&#44;241&#41; ou tratamento de suporte &#40;0&#44;186&#41;&#46; Assim&#44; o erlotinib mostrou-se &#8220;dominante&#8221; em segunda ou terceira linhas <span class="elsevierStyleItalic">versus</span> docetaxel e pemetrexedo&#46; A an&#225;lise de sensibilidade comprova a robustez dos resultados&#46;</p><p id="sp0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclus&#245;es&#58;</span> A substitui&#231;&#227;o de docetaxel ou pemetrexedo por erlotinib poderia contribuir para uma redu&#231;&#227;o anual dos gastos do SNS que se estima &#40;taxas substitui&#231;&#227;o&#58; 5&#37;-65&#37;&#41; com uma varia&#231;&#227;o entre 135 046&#8364;-1 755 602&#8364; e entre 291 801&#8364;-3 793 409&#8364;&#44; respectivamente&#44; e com ganho em termos de QALY&#46;</p><p id="sp0025" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2008&#59; XIV &#40;6&#41;&#58; 803-827</span></p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="as0010" class="elsevierStyleSection elsevierViewall"><p id="sp0030" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Aim&#58;</span> Evaluate costs and benefits of erlotinib as 2<span class="elsevierStyleSup">nd</span> or 3<span class="elsevierStyleSup">rd</span> line treatment of advanced or metastatic nonsmall cell lung cancer &#40;NSCLC&#41; <span class="elsevierStyleItalic">versus</span> docetaxel&#44; pemetrexed and best supportive care&#46;</p><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Materials and methods&#58;</span> Cost-minimisation and cost-utility analysis were performed&#46; Time horizon of two years&#46; Portuguese National Health System &#40;NHS&#41; perspective was applied&#46; Survival and time to progression were obtained from three clinical trials&#46; Base-case analysis&#58; 2<span class="elsevierStyleSup">nd</span> or 3<span class="elsevierStyleSup">rd</span> line patients with advanced or metastatic NSCLC&#46; Quality Adjusted Life Years &#40;QALYs&#41; were obtained from a UK study&#46; Resource consumption was estimated by a Portuguese panel of experts&#46; Costs were calculated according to official Portuguese databases &#40;updated to 2008&#41;&#46; Only direct health costs were applied&#46; Annual discount rate&#58; 5&#37;&#46; Sensitivity analysis included different subpopulations&#44; a three year time horizon and a probabilistic analysis&#46;</p><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Results&#58;</span> The cost per patient was lower with erlotinib &#40;&#8364;26 478&#41; than docetaxel &#40;&#8364;29 262&#41; or pemetrexed &#40;&#8364;32 762&#41; and higher than best supportive care &#40;&#8364;16 112&#41;&#46; QALYs per patient were higher with erlotinib &#40;0&#46;250&#41; than docetaxel &#40;0&#46;225&#41;&#44; pemetrexed &#40;0&#46;241&#41; or best supportive care &#40;0&#46;186&#41;&#46; Erlotinib was dominant in the cost-utility analysis&#44; with a lower cost and a higher efficacy than docetaxel and pemetrexed&#46; The sensitivity analysis confirmed the robustness of the base-case analysis results&#46;</p><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclusions&#58;</span> The use of erlotinib instead of docetaxel or pemetrexed could contribute to annual savings for the NHS &#40;substitution rates&#58; 5&#37;-65&#37;&#41; ranging from &#8364;135 046-&#8364;1 755 602 &#40;docetaxel replacement&#41; and &#8364;291 801-&#8364;3 793 409 &#40;pemetrexed replacement&#41;&#44; with a gain in terms of QALYs&#46;</p><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2008&#59; XIV &#40;6&#41;&#58; 803-827</span></p></span>"
      ]
    ]
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle" id="st0025">Bibliografia &#47; Bibliography</span>"
        "seccion" => array:1 [
          0 => array:2 [
            "vista" => "all"
            "bibliografiaReferencia" => array:14 [
              0 => array:3 [
                "identificador" => "bb0005"
                "etiqueta" => "1&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Chemotherapy in non-small cell lung cancer&#58; A meta-analysis using updated data on individual patients from 52 randomised clinical trials"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "Non-Small Cell Lung Cancer Collaborative Group"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "BMJ"
                          "fecha" => "1995"
                          "volumen" => "311"
                          "paginaInicial" => "899"
                          "paginaFinal" => "909"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7580546"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bb0010"
                "etiqueta" => "2&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Estudo epidemiol&#243;gico do cancro do pulm&#227;o em Portugal nos anos 2000&#47;2002"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:4 [
                              0 => "B&#46; Parente"
                              1 => "H&#46; Queiroga"
                              2 => "E&#46; Teixeira"
                              3 => "R&#46; Sotto-Mayor"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "Rev Port Pneumol"
                          "fecha" => "2007"
                          "volumen" => "XIII"
                          "numero" => "2"
                          "paginaInicial" => "255"
                          "paginaFinal" => "265"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              2 => array:3 [
                "identificador" => "bb0015"
                "etiqueta" => "3&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Henrique Barros&#44; Nuno Lunet&#44; Manuel Sobrinho Sim&#245;es&#46; O Cancro em Portugal&#46; Dispon&#237;vel em<a href="http://www.ipatimup.pt/medprev/paper3.pdf">http&#58;&#47;&#47;www&#46;ipatimup&#46;pt&#47;medprev&#47;paper3&#46;pdf</a>&#46;"
                  ]
                ]
              ]
              3 => array:3 [
                "identificador" => "bb0020"
                "etiqueta" => "4&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Valutazione econ&#243;mica di erlotinib&#44; docetaxel e pemetrexed nel trattamento di seconda l&#237;nea del carcinoma polmonare non a piccole cellule"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "S&#46; Capri"
                              1 => "A&#46; Morabito"
                              2 => "G&#46; Carillio"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "PharmacoEconomics &#8211; Italian Research Articles"
                          "fecha" => "2007"
                          "volumen" => "9"
                          "numero" => "2"
                          "paginaInicial" => "113"
                          "paginaFinal" => "124"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              4 => array:3 [
                "identificador" => "bb0025"
                "etiqueta" => "5&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento Tarceva&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/hu-mandocs/PDFs/EPAR/tarceva/H">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;hu-mandocs&#47;PDFs&#47;EPAR&#47;tarceva&#47;H</a> -618-PI-pt&#46;pdf&#59; consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              5 => array:3 [
                "identificador" => "bb0030"
                "etiqueta" => "6&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Dancey"
                              2 => "R&#46; Ramlau"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Onc"
                          "fecha" => "2000"
                          "volumen" => "18"
                          "numero" => "10"
                          "paginaInicial" => "2095"
                          "paginaFinal" => "2103"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              6 => array:3 [
                "identificador" => "bb0035"
                "etiqueta" => "7&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "N&#46; Hanna"
                              1 => "F&#46;A&#46; Shepherd"
                              2 => "F&#46;V&#46; Fossella"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Onc"
                          "fecha" => "2004"
                          "volumen" => "22"
                          "numero" => "9"
                          "paginaInicial" => "1589"
                          "paginaFinal" => "1597"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              7 => array:3 [
                "identificador" => "bb0040"
                "etiqueta" => "8&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "National Cancer Institute of Canada Clinical Trials Group&#46; Erlotinib in previously treated non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:19 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Rodrigues Pereira"
                              2 => "T&#46; Ciuleanu"
                              3 => "E&#46;H&#46; Tan"
                              4 => "V&#46; Hirsh"
                              5 => "S&#46; Thongprasert"
                              6 => "D&#46; Campos"
                              7 => "S&#46; Maoleekoonpiroj"
                              8 => "M&#46; Smylie"
                              9 => "R&#46; Martins"
                              10 => "M&#46; van Kooten"
                              11 => "M&#46; Dediu"
                              12 => "B&#46; Findlay"
                              13 => "D&#46; Tu"
                              14 => "D&#46; Johnston"
                              15 => "A&#46; Bezjak"
                              16 => "G&#46; Clark"
                              17 => "P&#46; Santab&#225;rbara"
                              18 => "L&#46; Seymour"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1056/NEJMoa050753"
                        "Revista" => array:7 [
                          "tituloSerie" => "N Engl J Med"
                          "fecha" => "2005"
                          "volumen" => "353"
                          "numero" => "2"
                          "paginaInicial" => "123"
                          "paginaFinal" => "132"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              8 => array:3 [
                "identificador" => "bb0045"
                "etiqueta" => "9&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "host" => array:1 [
                      0 => array:1 [
                        "Libro" => array:4 [
                          "titulo" => "Orienta&#231;&#245;es metodol&#243;gicas para estudos de avalia&#231;&#227;o econ&#243;mica de medicamentos"
                          "fecha" => "1999"
                          "editorial" => "INFARMED"
                          "editorialLocalizacion" => "Lisboa"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              9 => array:3 [
                "identificador" => "bb0050"
                "etiqueta" => "10&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento ALIMTA&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/humandocs/PDFs/EPAR/alimta/H-564-PI-pt.pdf">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;PDFs&#47;EPAR&#47;alimta&#47;H-564-PI-pt&#46;pdf</a>&#44; consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              10 => array:3 [
                "identificador" => "bb0055"
                "etiqueta" => "11&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento TAXOTERE&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/humandocs/PDFs/EPAR/taxotere/H-073-PI-pt.pdf">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;PDFs&#47;EPAR&#47;taxotere&#47;H-073-PI-pt&#46;pdf</a> consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              11 => array:3 [
                "identificador" => "bb0060"
                "etiqueta" => "12&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Contabilidade Anal&#237;tica 2005&#44; Hospitais do SNS&#46; Minist&#233;rio da Sa&#250;de&#44; IGIF&#46; Edi&#231;&#227;o 2006&#46;"
                  ]
                ]
              ]
              12 => array:3 [
                "identificador" => "bb0065"
                "etiqueta" => "13&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Infarmed &#91;<a href="http://www.infarmed.pt/formulario/in-dex.html">http&#58;&#47;&#47;www&#46;infarmed&#46;pt&#47;formulario&#47;in-dex&#46;html</a>&#93;&#46;"
                  ]
                ]
              ]
              13 => array:3 [
                "identificador" => "bb0070"
                "etiqueta" => "14&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Di&#225;rio da Rep&#250;blica&#44; 1&#46;&#170; s&#233;rie &#8211; N&#46;&#186;16&#44; Portaria n&#46;&#186; 110-A&#47;2007&#44; de 23 de Janeiro de 2007&#46;"
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302889/v1_201509151433/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9575"
    "tipo" => "SECCION"
    "pt" => array:2 [
      "titulo" => "Artigos originais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "pt"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000001400000006/v1_201509151433/S0873215915302889/v1_201509151433/pt/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302889?idApp=UINPBA00004E"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Artigo Original/Original Article
Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer
A. Araújo1, B. Parente2, R. Sotto-Mayor3, E. Teixeira4, T. Almodôvar5, F. Barata6, H. Queiroga7, C. Pereira8, H. Pereira9, F. Negreiro10, C. Silva11
1 Coordenador da Clínica de Patologia do Pulmão, Serviço de Oncologia Médica, Instituto Português de Oncologia Francisco Gentil – Centro do Porto, Portugal / Francisco Gentil Portuguese Oncology Institute, Centro do Porto, Lung Pathology Clinic Coordinator, Medical Oncology Unit, Porto, Portugal
2 Directora do Serviço de Pneumologia, Serviço de Pneumologia, Centro Hospitalar de V. N. Gaia, Portugal / Centro Hospitalar de V. N. Gaia, Head, Pulmonology Unit, Pulmonology Unit, V. N. Gaia, Portugal
3 Chefe de Serviço de Pneumologia, Serviço de Pneumologia do Hospital de Santa Maria, CHLN, Lisboa, Portugal / Head, Pulmonology Unit, Pulmonology Unit, Hospital de Santa Maria, CHLN, Lisbon, Portugal
4 Assistente Graduada de Pneumologia, Serviço de Pneumologia, Hospital de Santa Maria, Lisboa, Portugal / Hospital de Santa Maria, Consultant, Pulmonology specialist, Pulmonology Unit, Lisbon, Portugal
5 Serviço de Pneumologia; Instituto Português de Oncologia de Francisco Gentil, Lisboa, Portugal / Pulmonology Unit, Francisco Gentil Portuguese Oncology Institute, Lisbon, Portugal
6 Responsável de Pneumologia Oncológica, Centro Hospitalar de Coimbra, Portugal / Head, Pulmonary Oncology, Centro Hospitalar de Coimbra, Portugal
7 Coordenador da Consulta de Pneumologia Oncológica, Hospital de S. João, Porto; Portugal / Pulmonary Oncology Appointment Coordinator, Hospital de S. João, Porto, Portugal
8 Pharmacoeconomic Manager, Departamento de Market Access & Health Economics, Roche Farmacêutica Química, Lda.; Portugal / Pharmacoeconomic Manager, Market Access & Health Economics Unit, Roche Farmacêutica Química, Lda., Portugal
9 Medical Manager Oncologia Pulmão, Roche Farmacêutica Química, Lda., Portugal / Medical Manager, Pulmonary Oncology, Roche Farmacêutica Química, Lda., Portugal
10 Bioestatista, Eurotrials - Consultores Científicos, Lisboa, Portugal / Biostatistician, Eurotrials - Consultores Científicos, Lisbon, Portugal
11 Bioestatista Sénior, Eurotrials - Consultores Científicos, Lisboa; Portugal / Senior Biostatistician, Eurotrials - Consultores Científicos, Lisbon, Portugal
Ver más
Read
6428
Times
was read the article
2332
Total PDF
4096
Total HTML
Share statistics
 array:24 [
  "pii" => "S0873215915302889"
  "issn" => "08732159"
  "doi" => "10.1016/S0873-2159(15)30288-9"
  "estado" => "S350"
  "fechaPublicacion" => "2008-11-01"
  "aid" => "6"
  "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
  "copyrightAnyo" => "2008"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Pneumol. 2008;14:803-27"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3013
    "formatos" => array:3 [
      "EPUB" => 237
      "HTML" => 2041
      "PDF" => 735
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0873215915302890"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30289-0"
    "estado" => "S350"
    "fechaPublicacion" => "2008-11-01"
    "aid" => "7"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2008;14:829-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2425
      "formatos" => array:3 [
        "EPUB" => 243
        "HTML" => 1487
        "PDF" => 695
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "An&#225;lise comparativa entre tuberculose multirresistente e tuberculose extensivamente resistente &#8211; Epidemiologia e factores preditivos"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "829"
          "paginaFinal" => "842"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis &#8211; Epidemiology and predictive factors"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Sofia Vilari&#231;a, Carlos Gomes, Jaime Pina"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Sofia Vilari&#231;a"
            ]
            1 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Gomes"
            ]
            2 => array:2 [
              "nombre" => "Jaime"
              "apellidos" => "Pina"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302890?idApp=UINPBA00004E"
    "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302890/v1_201509151433/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0873215915302877"
    "issn" => "08732159"
    "doi" => "10.1016/S0873-2159(15)30287-7"
    "estado" => "S350"
    "fechaPublicacion" => "2008-11-01"
    "aid" => "5"
    "copyright" => "Sociedade Portuguesa de Pneumologia&#47;SPP"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2008;14:787-802"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2509
      "formatos" => array:3 [
        "EPUB" => 220
        "HTML" => 1540
        "PDF" => 749
      ]
    ]
    "pt" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
      "titulo" => "Corpos estranhos na via a&#233;rea&#58; Experi&#234;ncia de um quarto de s&#233;culo"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "pt"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "787"
          "paginaFinal" => "802"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Foreign bodies in the airway&#58; A quarter of a century&#8217;s experience"
        ]
      ]
      "contieneResumen" => array:2 [
        "pt" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Roda, Susana Nobre, Jorge Pires, M&#46; Helena Est&#234;v&#227;o, Miguel F&#233;lix"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Juliana"
              "apellidos" => "Roda"
            ]
            1 => array:2 [
              "nombre" => "Susana"
              "apellidos" => "Nobre"
            ]
            2 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Pires"
            ]
            3 => array:2 [
              "nombre" => "M&#46; Helena"
              "apellidos" => "Est&#234;v&#227;o"
            ]
            4 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "F&#233;lix"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302877?idApp=UINPBA00004E"
    "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302877/v1_201509151433/pt/main.assets"
  ]
  "pt" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original&#47;Original Article</span>"
    "titulo" => "Avalia&#231;&#227;o econ&#243;mica do erlotinib&#44; docetaxel&#44; pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "803"
        "paginaFinal" => "827"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; Ara&#250;jo, B&#46; Parente, R&#46; Sotto-Mayor, E&#46; Teixeira, T&#46; Almod&#244;var, F&#46; Barata, H&#46; Queiroga, C&#46; Pereira, H&#46; Pereira, F&#46; Negreiro, C&#46; Silva"
        "autores" => array:11 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Ara&#250;jo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "af0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "B&#46;"
            "apellidos" => "Parente"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">2</span>"
                "identificador" => "af0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "R&#46;"
            "apellidos" => "Sotto-Mayor"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">3</span>"
                "identificador" => "af0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "E&#46;"
            "apellidos" => "Teixeira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">4</span>"
                "identificador" => "af0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "T&#46;"
            "apellidos" => "Almod&#244;var"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">5</span>"
                "identificador" => "af0025"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "F&#46;"
            "apellidos" => "Barata"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">6</span>"
                "identificador" => "af0030"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "H&#46;"
            "apellidos" => "Queiroga"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">7</span>"
                "identificador" => "af0035"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Pereira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">8</span>"
                "identificador" => "af0040"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "H&#46;"
            "apellidos" => "Pereira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">9</span>"
                "identificador" => "af0045"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "F&#46;"
            "apellidos" => "Negreiro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">10</span>"
                "identificador" => "af0050"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "C&#46;"
            "apellidos" => "Silva"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">11</span>"
                "identificador" => "af0055"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:11 [
          0 => array:3 [
            "entidad" => "Coordenador da Cl&#237;nica de Patologia do Pulm&#227;o&#44; Servi&#231;o de Oncologia M&#233;dica&#44; Instituto Portugu&#234;s de Oncologia Francisco Gentil &#8211; Centro do Porto&#44; Portugal &#47; Francisco Gentil Portuguese Oncology Institute&#44; Centro do Porto&#44; Lung Pathology Clinic Coordinator&#44; Medical Oncology Unit&#44; Porto&#44; Portugal"
            "etiqueta" => "1"
            "identificador" => "af0005"
          ]
          1 => array:3 [
            "entidad" => "Directora do Servi&#231;o de Pneumologia&#44; Servi&#231;o de Pneumologia&#44; Centro Hospitalar de V&#46; N&#46; Gaia&#44; Portugal &#47; Centro Hospitalar de V&#46; N&#46; Gaia&#44; Head&#44; Pulmonology Unit&#44; Pulmonology Unit&#44; V&#46; N&#46; Gaia&#44; Portugal"
            "etiqueta" => "2"
            "identificador" => "af0010"
          ]
          2 => array:3 [
            "entidad" => "Chefe de Servi&#231;o de Pneumologia&#44; Servi&#231;o de Pneumologia do Hospital de Santa Maria&#44; CHLN&#44; Lisboa&#44; Portugal &#47; Head&#44; Pulmonology Unit&#44; Pulmonology Unit&#44; Hospital de Santa Maria&#44; CHLN&#44; Lisbon&#44; Portugal"
            "etiqueta" => "3"
            "identificador" => "af0015"
          ]
          3 => array:3 [
            "entidad" => "Assistente Graduada de Pneumologia&#44; Servi&#231;o de Pneumologia&#44; Hospital de Santa Maria&#44; Lisboa&#44; Portugal &#47; Hospital de Santa Maria&#44; Consultant&#44; Pulmonology specialist&#44; Pulmonology Unit&#44; Lisbon&#44; Portugal"
            "etiqueta" => "4"
            "identificador" => "af0020"
          ]
          4 => array:3 [
            "entidad" => "Servi&#231;o de Pneumologia&#59; Instituto Portugu&#234;s de Oncologia de Francisco Gentil&#44; Lisboa&#44; Portugal &#47; Pulmonology Unit&#44; Francisco Gentil Portuguese Oncology Institute&#44; Lisbon&#44; Portugal"
            "etiqueta" => "5"
            "identificador" => "af0025"
          ]
          5 => array:3 [
            "entidad" => "Respons&#225;vel de Pneumologia Oncol&#243;gica&#44; Centro Hospitalar de Coimbra&#44; Portugal &#47; Head&#44; Pulmonary Oncology&#44; Centro Hospitalar de Coimbra&#44; Portugal"
            "etiqueta" => "6"
            "identificador" => "af0030"
          ]
          6 => array:3 [
            "entidad" => "Coordenador da Consulta de Pneumologia Oncol&#243;gica&#44; Hospital de S&#46; Jo&#227;o&#44; Porto&#59; Portugal &#47; Pulmonary Oncology Appointment Coordinator&#44; Hospital de S&#46; Jo&#227;o&#44; Porto&#44; Portugal"
            "etiqueta" => "7"
            "identificador" => "af0035"
          ]
          7 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Pharmacoeconomic Manager</span>&#44; Departamento de Market Access &#38; Health Economics&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#59; Portugal &#47; Pharmacoeconomic Manager&#44; Market Access &#38; Health Economics Unit&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal"
            "etiqueta" => "8"
            "identificador" => "af0040"
          ]
          8 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Medical Manager</span> Oncologia Pulm&#227;o&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal &#47; Medical Manager&#44; Pulmonary Oncology&#44; Roche Farmac&#234;utica Qu&#237;mica&#44; Lda&#46;&#44; Portugal"
            "etiqueta" => "9"
            "identificador" => "af0045"
          ]
          9 => array:3 [
            "entidad" => "Bioestatista&#44; <span class="elsevierStyleItalic">Eurotrials</span> - Consultores Cient&#237;ficos&#44; Lisboa&#44; Portugal &#47; Biostatistician&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisbon&#44; Portugal"
            "etiqueta" => "10"
            "identificador" => "af0050"
          ]
          10 => array:3 [
            "entidad" => "Bioestatista S&#233;nior&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisboa&#59; Portugal &#47; Senior Biostatistician&#44; Eurotrials - Consultores Cient&#237;ficos&#44; Lisbon&#44; Portugal"
            "etiqueta" => "11"
            "identificador" => "af0055"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "An economic analysis of erlotinib&#44; docetaxel&#44; pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2008-08-22"
    "fechaAceptado" => "2008-09-11"
    "PalabrasClave" => array:2 [
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras-chave"
          "identificador" => "xpalclavsec570064"
          "palabras" => array:5 [
            0 => "Cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas"
            1 => "econ&#243;mico"
            2 => "Portugal"
            3 => "utilidade"
            4 => "custo-efectividade"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key-words"
          "identificador" => "xpalclavsec570065"
          "palabras" => array:5 [
            0 => "Non-small cell lung cancer"
            1 => "economics"
            2 => "Portugal"
            3 => "utility"
            4 => "cost-effectiveness"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="as0005" class="elsevierStyleSection elsevierViewall"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Objectivo&#58;</span> Avaliar o custo-efectividade de erlotinib na segunda ou terceira linha do tratamento do cancro do pulm&#227;o de n&#227;o pequenas c&#233;lulas &#40;CPNPC&#41; avan&#231;ado ou metastizado <span class="elsevierStyleItalic">versus</span> docetaxel&#44; pemetrexedo ou tratamento de suporte&#46;</p><p id="sp0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Material e m&#233;todos&#58;</span> An&#225;lises de minimiza&#231;&#227;o de custos e custo-utilidade&#46; Horizonte temporal&#58; dois anos&#46; Perspectiva do Sistema Nacional de Sa&#250;de &#40;SNS&#41; portugu&#234;s&#46; Sobreviv&#234;ncia e tempo at&#233; progress&#227;o obtidos a partir de tr&#234;s ensaios cl&#237;nicos&#46; An&#225;lise-base inclui doentes com CPNPC avan&#231;ado ou metastizado em segunda ou terceira linhas&#46; Anos de vida ajustados pela qualidade &#40;ou QALY&#41; obtidos a partir de estudo no Reino Unido&#46; Consumo de recursos estimado por painel de peritos portugueses&#46; Inclu&#237;ram-se apenas custos directos&#44; obtidos a partir de fontes oficiais &#40;pre&#231;os actualizados para 2008&#41;&#46; Taxa de actualiza&#231;&#227;o anual&#58; 5&#37;&#46; An&#225;lises de sensibilidade&#58; diferentes subpopula&#231;&#245;es&#44; horizonte temporal a tr&#234;s anos e an&#225;lise probabil&#237;stica&#46;</p><p id="sp0015" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Resultados&#58;</span> O custo total&#47;doente foi menor com erlotinib &#40;26 478&#8364;&#41; <span class="elsevierStyleItalic">versus</span> docetaxel &#40;29 262&#8364;&#41; ou pemetrexedo &#40;32 762&#8364;&#41; e superior <span class="elsevierStyleItalic">versus</span> tratamento de suporte &#40;16 112&#8364;&#41;&#46; Obtiveram-se QALY&#47;doente mais elevados com erlotinib &#40;0&#44;250&#41; <span class="elsevierStyleItalic">versus</span> docetaxel &#40;0&#44;225&#41;&#44; pemetrexedo &#40;0&#44;241&#41; ou tratamento de suporte &#40;0&#44;186&#41;&#46; Assim&#44; o erlotinib mostrou-se &#8220;dominante&#8221; em segunda ou terceira linhas <span class="elsevierStyleItalic">versus</span> docetaxel e pemetrexedo&#46; A an&#225;lise de sensibilidade comprova a robustez dos resultados&#46;</p><p id="sp0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclus&#245;es&#58;</span> A substitui&#231;&#227;o de docetaxel ou pemetrexedo por erlotinib poderia contribuir para uma redu&#231;&#227;o anual dos gastos do SNS que se estima &#40;taxas substitui&#231;&#227;o&#58; 5&#37;-65&#37;&#41; com uma varia&#231;&#227;o entre 135 046&#8364;-1 755 602&#8364; e entre 291 801&#8364;-3 793 409&#8364;&#44; respectivamente&#44; e com ganho em termos de QALY&#46;</p><p id="sp0025" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2008&#59; XIV &#40;6&#41;&#58; 803-827</span></p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="as0010" class="elsevierStyleSection elsevierViewall"><p id="sp0030" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Aim&#58;</span> Evaluate costs and benefits of erlotinib as 2<span class="elsevierStyleSup">nd</span> or 3<span class="elsevierStyleSup">rd</span> line treatment of advanced or metastatic nonsmall cell lung cancer &#40;NSCLC&#41; <span class="elsevierStyleItalic">versus</span> docetaxel&#44; pemetrexed and best supportive care&#46;</p><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Materials and methods&#58;</span> Cost-minimisation and cost-utility analysis were performed&#46; Time horizon of two years&#46; Portuguese National Health System &#40;NHS&#41; perspective was applied&#46; Survival and time to progression were obtained from three clinical trials&#46; Base-case analysis&#58; 2<span class="elsevierStyleSup">nd</span> or 3<span class="elsevierStyleSup">rd</span> line patients with advanced or metastatic NSCLC&#46; Quality Adjusted Life Years &#40;QALYs&#41; were obtained from a UK study&#46; Resource consumption was estimated by a Portuguese panel of experts&#46; Costs were calculated according to official Portuguese databases &#40;updated to 2008&#41;&#46; Only direct health costs were applied&#46; Annual discount rate&#58; 5&#37;&#46; Sensitivity analysis included different subpopulations&#44; a three year time horizon and a probabilistic analysis&#46;</p><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Results&#58;</span> The cost per patient was lower with erlotinib &#40;&#8364;26 478&#41; than docetaxel &#40;&#8364;29 262&#41; or pemetrexed &#40;&#8364;32 762&#41; and higher than best supportive care &#40;&#8364;16 112&#41;&#46; QALYs per patient were higher with erlotinib &#40;0&#46;250&#41; than docetaxel &#40;0&#46;225&#41;&#44; pemetrexed &#40;0&#46;241&#41; or best supportive care &#40;0&#46;186&#41;&#46; Erlotinib was dominant in the cost-utility analysis&#44; with a lower cost and a higher efficacy than docetaxel and pemetrexed&#46; The sensitivity analysis confirmed the robustness of the base-case analysis results&#46;</p><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Conclusions&#58;</span> The use of erlotinib instead of docetaxel or pemetrexed could contribute to annual savings for the NHS &#40;substitution rates&#58; 5&#37;-65&#37;&#41; ranging from &#8364;135 046-&#8364;1 755 602 &#40;docetaxel replacement&#41; and &#8364;291 801-&#8364;3 793 409 &#40;pemetrexed replacement&#41;&#44; with a gain in terms of QALYs&#46;</p><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Rev Port Pneumol 2008&#59; XIV &#40;6&#41;&#58; 803-827</span></p></span>"
      ]
    ]
    "lecturaRecomendada" => array:1 [
      0 => array:3 [
        "vista" => "all"
        "titulo" => "<span class="elsevierStyleSectionTitle" id="st0025">Bibliografia &#47; Bibliography</span>"
        "seccion" => array:1 [
          0 => array:2 [
            "vista" => "all"
            "bibliografiaReferencia" => array:14 [
              0 => array:3 [
                "identificador" => "bb0005"
                "etiqueta" => "1&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Chemotherapy in non-small cell lung cancer&#58; A meta-analysis using updated data on individual patients from 52 randomised clinical trials"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:1 [
                              0 => "Non-Small Cell Lung Cancer Collaborative Group"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "BMJ"
                          "fecha" => "1995"
                          "volumen" => "311"
                          "paginaInicial" => "899"
                          "paginaFinal" => "909"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7580546"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              1 => array:3 [
                "identificador" => "bb0010"
                "etiqueta" => "2&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Estudo epidemiol&#243;gico do cancro do pulm&#227;o em Portugal nos anos 2000&#47;2002"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:4 [
                              0 => "B&#46; Parente"
                              1 => "H&#46; Queiroga"
                              2 => "E&#46; Teixeira"
                              3 => "R&#46; Sotto-Mayor"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "Rev Port Pneumol"
                          "fecha" => "2007"
                          "volumen" => "XIII"
                          "numero" => "2"
                          "paginaInicial" => "255"
                          "paginaFinal" => "265"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              2 => array:3 [
                "identificador" => "bb0015"
                "etiqueta" => "3&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Henrique Barros&#44; Nuno Lunet&#44; Manuel Sobrinho Sim&#245;es&#46; O Cancro em Portugal&#46; Dispon&#237;vel em<a href="http://www.ipatimup.pt/medprev/paper3.pdf">http&#58;&#47;&#47;www&#46;ipatimup&#46;pt&#47;medprev&#47;paper3&#46;pdf</a>&#46;"
                  ]
                ]
              ]
              3 => array:3 [
                "identificador" => "bb0020"
                "etiqueta" => "4&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Valutazione econ&#243;mica di erlotinib&#44; docetaxel e pemetrexed nel trattamento di seconda l&#237;nea del carcinoma polmonare non a piccole cellule"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "S&#46; Capri"
                              1 => "A&#46; Morabito"
                              2 => "G&#46; Carillio"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "PharmacoEconomics &#8211; Italian Research Articles"
                          "fecha" => "2007"
                          "volumen" => "9"
                          "numero" => "2"
                          "paginaInicial" => "113"
                          "paginaFinal" => "124"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              4 => array:3 [
                "identificador" => "bb0025"
                "etiqueta" => "5&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento Tarceva&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/hu-mandocs/PDFs/EPAR/tarceva/H">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;hu-mandocs&#47;PDFs&#47;EPAR&#47;tarceva&#47;H</a> -618-PI-pt&#46;pdf&#59; consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              5 => array:3 [
                "identificador" => "bb0030"
                "etiqueta" => "6&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Dancey"
                              2 => "R&#46; Ramlau"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Onc"
                          "fecha" => "2000"
                          "volumen" => "18"
                          "numero" => "10"
                          "paginaInicial" => "2095"
                          "paginaFinal" => "2103"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              6 => array:3 [
                "identificador" => "bb0035"
                "etiqueta" => "7&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => true
                            "autores" => array:3 [
                              0 => "N&#46; Hanna"
                              1 => "F&#46;A&#46; Shepherd"
                              2 => "F&#46;V&#46; Fossella"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:1 [
                        "Revista" => array:6 [
                          "tituloSerie" => "J Clin Onc"
                          "fecha" => "2004"
                          "volumen" => "22"
                          "numero" => "9"
                          "paginaInicial" => "1589"
                          "paginaFinal" => "1597"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              7 => array:3 [
                "identificador" => "bb0040"
                "etiqueta" => "8&#46;"
                "referencia" => array:1 [
                  0 => array:2 [
                    "contribucion" => array:1 [
                      0 => array:2 [
                        "titulo" => "National Cancer Institute of Canada Clinical Trials Group&#46; Erlotinib in previously treated non-small-cell lung cancer"
                        "autores" => array:1 [
                          0 => array:2 [
                            "etal" => false
                            "autores" => array:19 [
                              0 => "F&#46;A&#46; Shepherd"
                              1 => "J&#46; Rodrigues Pereira"
                              2 => "T&#46; Ciuleanu"
                              3 => "E&#46;H&#46; Tan"
                              4 => "V&#46; Hirsh"
                              5 => "S&#46; Thongprasert"
                              6 => "D&#46; Campos"
                              7 => "S&#46; Maoleekoonpiroj"
                              8 => "M&#46; Smylie"
                              9 => "R&#46; Martins"
                              10 => "M&#46; van Kooten"
                              11 => "M&#46; Dediu"
                              12 => "B&#46; Findlay"
                              13 => "D&#46; Tu"
                              14 => "D&#46; Johnston"
                              15 => "A&#46; Bezjak"
                              16 => "G&#46; Clark"
                              17 => "P&#46; Santab&#225;rbara"
                              18 => "L&#46; Seymour"
                            ]
                          ]
                        ]
                      ]
                    ]
                    "host" => array:1 [
                      0 => array:2 [
                        "doi" => "10.1056/NEJMoa050753"
                        "Revista" => array:7 [
                          "tituloSerie" => "N Engl J Med"
                          "fecha" => "2005"
                          "volumen" => "353"
                          "numero" => "2"
                          "paginaInicial" => "123"
                          "paginaFinal" => "132"
                          "link" => array:1 [
                            0 => array:2 [
                              "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16014882"
                              "web" => "Medline"
                            ]
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              8 => array:3 [
                "identificador" => "bb0045"
                "etiqueta" => "9&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "host" => array:1 [
                      0 => array:1 [
                        "Libro" => array:4 [
                          "titulo" => "Orienta&#231;&#245;es metodol&#243;gicas para estudos de avalia&#231;&#227;o econ&#243;mica de medicamentos"
                          "fecha" => "1999"
                          "editorial" => "INFARMED"
                          "editorialLocalizacion" => "Lisboa"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
              9 => array:3 [
                "identificador" => "bb0050"
                "etiqueta" => "10&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento ALIMTA&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/humandocs/PDFs/EPAR/alimta/H-564-PI-pt.pdf">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;PDFs&#47;EPAR&#47;alimta&#47;H-564-PI-pt&#46;pdf</a>&#44; consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              10 => array:3 [
                "identificador" => "bb0055"
                "etiqueta" => "11&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Resumo das Caracter&#237;sticas do Medicamento TAXOTERE&#174;&#46; Dispon&#237;vel em <a href="http://www.emea.europa.eu/humandocs/PDFs/EPAR/taxotere/H-073-PI-pt.pdf">http&#58;&#47;&#47;www&#46;emea&#46;europa&#46;eu&#47;humandocs&#47;PDFs&#47;EPAR&#47;taxotere&#47;H-073-PI-pt&#46;pdf</a> consulta em Julho 2008&#46;"
                  ]
                ]
              ]
              11 => array:3 [
                "identificador" => "bb0060"
                "etiqueta" => "12&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Contabilidade Anal&#237;tica 2005&#44; Hospitais do SNS&#46; Minist&#233;rio da Sa&#250;de&#44; IGIF&#46; Edi&#231;&#227;o 2006&#46;"
                  ]
                ]
              ]
              12 => array:3 [
                "identificador" => "bb0065"
                "etiqueta" => "13&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Infarmed &#91;<a href="http://www.infarmed.pt/formulario/in-dex.html">http&#58;&#47;&#47;www&#46;infarmed&#46;pt&#47;formulario&#47;in-dex&#46;html</a>&#93;&#46;"
                  ]
                ]
              ]
              13 => array:3 [
                "identificador" => "bb0070"
                "etiqueta" => "14&#46;"
                "referencia" => array:1 [
                  0 => array:1 [
                    "referenciaCompleta" => "Di&#225;rio da Rep&#250;blica&#44; 1&#46;&#170; s&#233;rie &#8211; N&#46;&#186;16&#44; Portaria n&#46;&#186; 110-A&#47;2007&#44; de 23 de Janeiro de 2007&#46;"
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/08732159/0000001400000006/v1_201509151433/S0873215915302889/v1_201509151433/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9575"
    "tipo" => "SECCION"
    "pt" => array:2 [
      "titulo" => "Artigos originais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "pt"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000001400000006/v1_201509151433/S0873215915302889/v1_201509151433/pt/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0873215915302889?idApp=UINPBA00004E"
]
Article information
ISSN: 08732159
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 6 3 9
2024 October 40 34 74
2024 September 28 36 64
2024 August 51 51 102
2024 July 49 37 86
2024 June 40 28 68
2024 May 58 34 92
2024 April 50 25 75
2024 March 33 27 60
2024 February 31 27 58
2024 January 24 21 45
2023 December 19 41 60
2023 November 20 23 43
2023 October 27 57 84
2023 September 33 32 65
2023 August 36 21 57
2023 July 47 36 83
2023 June 32 16 48
2023 May 52 26 78
2023 April 16 20 36
2023 March 43 15 58
2023 February 65 32 97
2023 January 36 20 56
2022 December 29 23 52
2022 November 45 40 85
2022 October 34 31 65
2022 September 29 30 59
2022 August 24 49 73
2022 July 20 37 57
2022 June 28 30 58
2022 May 41 31 72
2022 April 34 41 75
2022 March 16 28 44
2022 February 26 24 50
2022 January 32 37 69
2021 December 20 37 57
2021 November 24 33 57
2021 October 40 34 74
2021 September 32 29 61
2021 August 18 24 42
2021 July 27 26 53
2021 June 20 24 44
2021 May 35 33 68
2021 April 31 53 84
2021 March 36 30 66
2021 February 50 13 63
2021 January 25 9 34
2020 December 32 12 44
2020 November 35 18 53
2020 October 20 12 32
2020 September 74 28 102
2020 August 40 14 54
2020 July 73 28 101
2020 June 57 15 72
2020 May 53 20 73
2020 April 51 21 72
2020 March 47 15 62
2020 February 45 19 64
2020 January 50 17 67
2019 December 39 23 62
2019 November 62 21 83
2019 October 35 17 52
2019 September 47 30 77
2019 August 88 18 106
2019 July 62 18 80
2019 June 70 13 83
2019 May 87 37 124
2019 April 78 29 107
2019 March 103 14 117
2019 February 110 22 132
2019 January 96 26 122
2018 December 32 10 42
2018 November 20 1 21
2018 October 31 7 38
2018 September 26 8 34
2018 August 48 29 77
2018 July 48 21 69
2018 June 67 17 84
2018 May 89 20 109
2018 April 68 36 104
2018 March 77 36 113
2018 February 61 12 73
2018 January 68 17 85
2017 December 91 18 109
2017 November 50 13 63
2017 October 25 18 43
2017 September 32 7 39
2017 August 36 13 49
2017 July 36 11 47
2017 June 31 13 44
2017 May 36 20 56
2017 April 8 4 12
2017 March 12 28 40
2017 February 13 5 18
2017 January 15 8 23
2016 December 11 5 16
2016 November 8 4 12
2016 October 11 8 19
2016 September 3 5 8
2016 August 4 2 6
2016 July 4 5 9
2016 June 0 4 4
2016 May 2 4 6
2016 April 2 4 6
2016 March 1 5 6
2016 February 5 6 11
2016 January 5 5 10
2015 December 9 1 10
2015 November 3 5 8
2015 October 2 2 4
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?